Candel Therapeutics, Inc. (CADL)
6.20
-2.19
(-26.10%)
USD |
NASDAQ |
Nov 13, 16:00
6.05
-0.15
(-2.42%)
After-Hours: 19:59
Candel Therapeutics Price : 6.20 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 5.325 | 6.63 | 5.20 | 6.20 | 6.622M |
| Nov 12, 2026 | 9.11 | 9.21 | 8.335 | 8.39 | 1.935M |
| Nov 11, 2026 | 9.53 | 9.54 | 9.18 | 9.22 | 1.097M |
| Nov 10, 2026 | 9.40 | 9.65 | 9.089 | 9.35 | 623545.0 |
| Nov 09, 2026 | 8.99 | 9.84 | 8.65 | 9.49 | 1.371M |
| Nov 06, 2026 | 8.24 | 8.75 | 8.06 | 8.75 | 955021.0 |
| Nov 05, 2026 | 8.98 | 9.009 | 7.92 | 8.04 | 1.228M |
| Nov 04, 2026 | 8.93 | 9.33 | 8.71 | 9.05 | 993819.0 |
| Nov 03, 2026 | 8.19 | 8.86 | 8.19 | 8.82 | 3.304M |
| Nov 02, 2026 | 8.35 | 8.61 | 8.011 | 8.12 | 862018.0 |
| Oct 30, 2026 | 8.56 | 8.61 | 8.16 | 8.33 | 779926.0 |
| Oct 29, 2026 | 8.72 | 8.93 | 8.553 | 8.65 | 740959.0 |
| Oct 28, 2026 | 8.13 | 8.69 | 8.13 | 8.67 | 663860.0 |
| Oct 27, 2026 | 7.78 | 8.37 | 7.741 | 8.25 | 928461.0 |
| Oct 26, 2026 | 8.44 | 8.44 | 7.70 | 7.79 | 849302.0 |
| Oct 23, 2026 | 8.33 | 8.33 | 7.905 | 8.03 | 1.185M |
| Oct 22, 2026 | 8.45 | 8.79 | 8.255 | 8.38 | 762579.0 |
| Oct 21, 2026 | 8.65 | 8.82 | 8.35 | 8.37 | 1.103M |
| Oct 20, 2026 | 8.17 | 8.84 | 8.125 | 8.64 | 1.126M |
| Oct 19, 2026 | 8.37 | 8.499 | 7.96 | 8.21 | 1.279M |
| Oct 16, 2026 | 8.92 | 8.92 | 8.125 | 8.19 | 1.513M |
| Oct 15, 2026 | 9.01 | 9.100 | 8.79 | 8.91 | 989339.0 |
| Oct 14, 2026 | 9.06 | 9.43 | 9.03 | 9.07 | 989443.0 |
| Oct 13, 2026 | 9.78 | 9.845 | 9.22 | 9.27 | 1.133M |
| Oct 12, 2026 | 10.00 | 10.18 | 9.71 | 9.78 | 744631.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Oragenics, Inc. | 0.201 |
| Arcturus Therapeutics Holdings, Inc. | 8.36 |
| ACADIA Pharmaceuticals, Inc. | 18.75 |
| Alnylam Pharmaceuticals, Inc. | 165.04 |
| Anika Therapeutics, Inc. | 13.40 |
Price Related Metrics
| PEG Ratio | -0.0252 |
| Price to Book Value | 3.696 |
| Earnings Yield | -23.98% |
| Market Cap | 471.93M |
| PEGY Ratio | -0.0252 |